Cynthia Kwan

7PUBLICATIONS
8CO-AUTHORS
Toxicology (incl. clinical toxicology)PharmacogenomicsClinical pharmacology and therapeuticsPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 22, 2025
The anti-dyskinetic effect of the clinic-ready mGluR<sub>2 </sub>positive allosteric modulator AZD8529 in the 6-OHDA-lesioned rat.

Judy Shaqfah, Woojin Kang, Fleur Gaudette

|Mar 25, 2024
[<sup>3</sup>H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain.

Imane Frouni, Esther Kim, Judy Shaqfah

|May 20, 2022
An overview of the active clinical trials for Parkinson's disease psychosis.

Cynthia Kwan, Philippe Huot

|Dec 23, 2021
Levodopa-induced dyskinesia: a brief review of the ongoing clinical trials.

Philippe Huot, Woojin Kang, Esther Kim

|May 08, 2021
Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset.

Cynthia Kwan, Stephen G Nuara, Jim C Gourdon

|Jan 04, 2021
Effect of the mGlu<sub>2</sub> positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.

Imane Frouni, Cynthia Kwan, Stephen G Nuara

Pageof 2